GlaxoSmithKline Pharmaceuticals posted a jump in net profit by 19 per cent to Rs 114.8 crore for the quarter ended June 30, 2008 compared to Rs 96.4 crore in the corresponding period last year.


</p><tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>The growth in net sales (net of excise and excluding the fine chemicals business) was 11.2 per cent during the quarter ended June 30, 2008. The growth in gross sales (excluding the fine chemicals business) during the first quarter of FY09 was impacted due to lower selling prices as a result of the excise benefit passed on to the consumer, said the company in a release to the Bombay Stock Exchange today. </P></p><p class='TableClas'></p></table>


GSK Pharma net up 19% at Rs 114.8 crore

More From This Section

Posco land acquisition resumes amid protests

Diageo to buy half of Mallya's South Africa beer biz

Average money spent for new players dips

'IndiGo did not comply with AAC guidelines'

Explore News